Drug History: TAMIFLU

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	TAMIFLU
FDA Application No:	(NDA) 021087
Active Ingredient(s):	OSELTAMIVIR PHOSPHATE
Company:	ROCHE

Label History

View the label approved on October 10, 2007 for TAMIFLU, (NDA) 021087

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
10/5/2007	041	Labeling Revision	Letter Label
7/2/2007	040	Formulation Revision	Letter Label
11/13/2006	033	Labeling Revision	Letter Label Patient Package Insert
12/21/2005	030	Supplement	Letter Label Patient Package Insert
8/16/2005	026	Labeling Revision	Letter Label
10/27/2005	025	Labeling Revision	Letter Label
4/20/2005	023	Package Change	Letter Label
6/24/2004	016	Labeling Revision	Letter Label Review
5/7/2002	012	Expiration Date Change	Review Other Important Information from FDA
3/28/2002	011	Expiration Date Change	Review
4/26/2002	010	Labeling Revision	Letter Label Review
11/5/2001	009	Labeling Revision	Label Review
7/24/2001	008	Labeling Revision	Label Review
7/13/2001	007	Expiration Date Change	Review
7/24/2001	006	Labeling Revision	Label Review
7/24/2001	005	Labeling Revision	Label Review
3/6/2001	004	Control Supplement	Review
11/9/2000	003	Expiration Date Change	Review
11/17/2000	002	New or Modified Indication	Letter Label Review
10/31/2000	001	Manufacturing Change or Addition	Review
10/27/1999	000	Approval	Letter Label Review Other Important Information from FDA

There are no Therapeutic Equivalents